申请人:Bayer Schering Pharma Aktiengesellschaft
公开号:US08076355B2
公开(公告)日:2011-12-13
The invention relates to novel 2-heteroarylcarboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
本发明涉及新型2-杂环基羧酰胺、其制备方法以及用于制备治疗和/或预防疾病、改善感知、注意力、学习和/或记忆的药物的用途。